Merck (MRK) Receivables - Net (2009 - 2026)

Merck (MRK) has 18 years of Receivables - Net data on file, last reported at $12.2 billion in Q1 2026.

• Quarterly Receivables - Net rose 13.16% year-over-year to $12.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 billion (up 13.16% YoY) and the FY2025 annual result came in at $11.8 billion, up 14.57% from the prior year.
• Receivables - Net rose to $12.2 billion in Q1 2026 per MRK's latest filing, from $11.8 billion in the prior quarter.
• Across five years, Receivables - Net topped out at $12.2 billion in Q1 2026 and bottomed at $260.0 million in Q3 2023.
• The 5-year median for Receivables - Net is $10.8 billion (2025), against an average of $10.2 billion.
• The widest annual swing landed in 2023, when Receivables - Net plunged 97.26%; it then surged 4277.31% in 2024.
• Tracing MRK's Receivables - Net over 5 years: stood at $9.5 billion in 2022, then increased by 9.51% to $10.3 billion in 2023, then slipped by 0.69% to $10.3 billion in 2024, then increased by 14.57% to $11.8 billion in 2025, then gained by 3.69% to $12.2 billion in 2026.
• Per Business Quant, the three latest MRK Receivables - Net figures stand at $12.2 billion (Q1 2026), $11.8 billion (Q4 2025), and $12.1 billion (Q3 2025).

Peer Comparison